FibroBiologics Inc

NAS:FBLG (USA)  
$ 2.31 +0.21 (+10%) 01:00 PM EST
At Loss
P/B:
26.25
Market Cap:
$ 75.20M
Enterprise V:
$ 71.37M
Volume:
91.04K
Avg Vol (2M):
162.99K
Trade In:
Volume:
91.04K
At Loss
Avg Vol (2M):
162.99K

Business Description

Description
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
Name Current Vs Industry Vs History
Cash-To-Debt 5.01
Equity-to-Asset 0.26
Debt-to-Equity 0.57
Debt-to-EBITDA -0.09
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.75
9-Day RSI 38.06
14-Day RSI 39.29
6-1 Month Momentum % -45.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.23
Quick Ratio 1.23
Cash Ratio 1.17

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -7.13
Name Current Vs Industry Vs History
ROE % -1073.87
ROA % -159.03
ROIC % -149.3
ROC (Joel Greenblatt) % -731.51
ROCE % -607.98

Financials (Next Earnings Date:2025-02-28 Est.)

FBLG's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FBLG

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

FibroBiologics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.549
Beta 0
Volatility % 0
14-Day RSI 39.29
14-Day ATR ($) 0.289623
20-Day SMA ($) 2.371
12-1 Month Momentum % 0
52-Week Range ($) 1.0779 - 55
Shares Outstanding (Mil) 35.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

FibroBiologics Inc Filings

Filing Date Document Date Form
No Filing Data

FibroBiologics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

FibroBiologics Inc Frequently Asked Questions

What is FibroBiologics Inc(FBLG)'s stock price today?
The current price of FBLG is $2.31. The 52 week high of FBLG is $55.00 and 52 week low is $1.08.
When is next earnings date of FibroBiologics Inc(FBLG)?
The next earnings date of FibroBiologics Inc(FBLG) is 2025-02-28 Est..
Does FibroBiologics Inc(FBLG) pay dividends? If so, how much?
FibroBiologics Inc(FBLG) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1